Efficacy and Safety Study of GB-0998 for Treatment of Steroid-resistant Polymyositis and Dermatomyositis (PM/DM)
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
This randomized, double-blind, placebo-controlled trial will carry out to assess the efficacy
of GB-0998 in the treatment of the steroid-resistant polymyositis and dermatomyositis based
on the changes in manual muscle strength (MMT) scores as primary endpoint, and in addition,
to assess the safety of GB-0998.